Evidence map›Paper›PMID 41354832›Full record

ArticleJournal of animal science and biotechnology2025

Dietary supplementation with sodium isobutyrate enhances growth performance and colonic barrier function in weaned piglets via microbiota-metabolite-host interactions.

Xiuyu Fang, Zihan Chi, Zhengyi Wang, Xinlin Wang, Xingrui Qu, Shuang Zhang, Feng Gao, Baoming Shi, Xuan Zhao

Abstract read
In one paragraph

Article in Journal of animal science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiuyu Fang *College of Animal Science and Technology, Southwest University, Chongqing, 400715, People's Republic of China.ORCID http://orcid.org/0009-0007-5862-814X
Zihan Chi *College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Zhengyi WangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Xinlin WangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Xingrui QuCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Shuang ZhangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Feng GaoCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China.
Baoming ShiCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, People's Republic of China. shibaoming1974@163.com.ORCID http://orcid.org/0000-0001-8560-4564
Xuan ZhaoCollege of Animal Science and Technology, Southwest University, Chongqing, 400715, People's Republic of China. zhaoxuann@swu.edu.cn.ORCID http://orcid.org/0009-0002-2020-752X

Funding

the CAST Youth Talent Support Project-Special Program for Doctoral Students 156-O-230-0000375-5The National Natural Science Foundation of China 32302759The National Natural Science Foundation of China 32372924
6 · The paper itself

Abstract

backgroundWeaning-induced diarrhoea and growth retardation in piglets are associated with impaired intestinal barrier function and decreased levels of colonic short-chain fatty acids (SCFAs). Although SCFA supplementation has been proposed to mitigate these issues, the efficacy and optimal dosage of sodium isobutyrate remain unclear.

resultsWe investigated the effects of sodium isobutyrate supplementation (500, 1,000, 2,000, and 4,000 mg/kg diet) on weaned piglets (Duroc × Landrace × Yorkshire, 28 d of age; n = 8). After a 28-d feeding trial, supplementation at 500-2,000 mg/kg significantly improved average daily gain and feed efficiency and reduced diarrhoea frequency, with maximal benefits observed at 1,000 mg/kg (P < 0.0001). Additionally, 500-1,000 mg/kg sodium isobutyrate supplementation increased the apparent digestibility of crude protein, organic matter, and crude fibre (P < 0.05). Serum biochemical parameters were unaffected, although secretory immunoglobulin A (SIgA) levels significantly increased upon supplementation with 500-1,000 mg/kg (P < 0.05). 16S rRNA gene sequencing indicated that sodium isobutyrate increased the abundance of beneficial colonic microbiota. The 1,000 mg/kg group presented the most pronounced effect, with a significant increase of the relative abundance of Prevotella and the greatest improvement in SCFA concentrations (P < 0.05). Metabolomics revealed elevated levels of colonic indole-3-lactic acid and 3-hydroxybutyrate upon supplementation with 1,000 mg/kg (P < 0.05). Transcriptomic analyses indicated activation of protein digestion and absorption pathways, and PI3K-Akt signalling, marked by TSG-6 upregulation and the suppression of ISG15 and DDIT4 expression (P < 0.05). Supplementation with 1,000 mg/kg was associated with improved intestinal barrier-related markers, including reduced serum D-lactate, diamine oxidase, and lipopolysaccharide levels, increased tight junction protein expression; activation of G protein-coupled receptors; and inhibition of TLR4/MyD88/NF-κB signalling (P < 0.05), suggesting enhanced barrier function.

conclusionsIn conclusion, dietary supplementation with 1,000 mg/kg sodium isobutyrate was associated with improved intestinal morphology, reduced serum permeability, increased expression of tight junction proteins, and enhanced immune function in weaned piglets, suggesting enhanced colonic barrier function and providing dosage guidance and mechanistic insights for future applications.

Indexed as

Colonic barrier functionDiarrhoeaIntestinal microbiotaSodium isobutyrateWeaned piglets

Identifiers

PMID41354832
PMCPMC12683800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.